HK1221463A1 - 可用作 抑制劑的新型化合物 - Google Patents
可用作 抑制劑的新型化合物Info
- Publication number
- HK1221463A1 HK1221463A1 HK16109566.7A HK16109566A HK1221463A1 HK 1221463 A1 HK1221463 A1 HK 1221463A1 HK 16109566 A HK16109566 A HK 16109566A HK 1221463 A1 HK1221463 A1 HK 1221463A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- inhibitors
- novel compounds
- compounds useful
- useful
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Cosmetics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14169757 | 2014-05-23 | ||
| PCT/EP2015/061468 WO2015177367A1 (en) | 2014-05-23 | 2015-05-22 | Novel compounds useful as s100-inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1221463A1 true HK1221463A1 (zh) | 2017-06-02 |
Family
ID=50774707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16109566.7A HK1221463A1 (zh) | 2014-05-23 | 2016-08-11 | 可用作 抑制劑的新型化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9771372B2 (zh) |
| EP (1) | EP2991990B1 (zh) |
| JP (1) | JP6580074B2 (zh) |
| KR (1) | KR20170005868A (zh) |
| CN (1) | CN106414448B (zh) |
| AU (1) | AU2015261775B2 (zh) |
| BR (1) | BR112016024749A2 (zh) |
| CA (1) | CA2948436A1 (zh) |
| EA (1) | EA030604B1 (zh) |
| ES (1) | ES2620751T3 (zh) |
| HK (1) | HK1221463A1 (zh) |
| MX (1) | MX2016014483A (zh) |
| WO (1) | WO2015177367A1 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7392951B2 (ja) | 2018-04-27 | 2023-12-06 | 国立大学法人 岡山大学 | 抗ｓ１００ａ８／ａ９抗体とその用途 |
| US11197908B2 (en) | 2018-07-17 | 2021-12-14 | The Board Of Trustees Of The University Of Arkansas | Peptoids and methods for attenuating inflammatory response |
| CA3155346A1 (en) | 2019-10-30 | 2021-05-06 | National University Corporation Okayama University | Prophylactic and/or therapeutic agent for inflammatory pulmonary disease |
| WO2023209141A1 (en) | 2022-04-29 | 2023-11-02 | Westfälische Wilhelms-Universität Münster | Benzo[d]imidazo[1,2-a]imidazoles and their use in diagnosis |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6248755B1 (en) | 1999-04-06 | 2001-06-19 | Merck & Co., Inc. | Pyrrolidine modulators of chemokine receptor activity |
| AR029489A1 (es) | 2000-03-10 | 2003-07-02 | Euro Celtique Sa | Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento |
| US7087632B2 (en) * | 2001-03-05 | 2006-08-08 | Transtech Pharma, Inc. | Benzimidazole derivatives as therapeutic agents |
| AU2001289749B9 (en) | 2000-07-26 | 2004-08-19 | Smithkline Beecham P.L.C. | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| GB0117506D0 (en) | 2001-07-18 | 2001-09-12 | Bayer Ag | Imidazopyridinones |
| SE0104331D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Novel compounds |
| CN101613321A (zh) * | 2002-03-05 | 2009-12-30 | 特兰斯泰克制药公司 | 抑制配体与高级糖化终产物受体相互作用的单和双环吡咯衍生物 |
| US20060111416A1 (en) | 2004-11-24 | 2006-05-25 | Lane Charlotte A L | Octahydropyrrolo[3,4-C]pyrrole derivatives |
| JP2010504980A (ja) | 2006-09-28 | 2010-02-18 | エグゼリクシス， インコーポレイテッド | Ｊａｋ−２モジュレーターおよび使用方法 |
| JP2010522177A (ja) | 2007-03-23 | 2010-07-01 | アムジエン・インコーポレーテツド | 複素環化合物およびその使用 |
| EP1986009A1 (en) * | 2007-04-26 | 2008-10-29 | Active Biotech AB | Screening method |
| BRPI0812521A2 (pt) | 2007-06-13 | 2015-06-23 | Glaxosmithkline Llc | Composto, composição farmacêutica, método para o tratamento de doença em um mamífero, processo para a preparação de um composto, e, uso de um composto |
| WO2009093747A1 (en) * | 2008-01-22 | 2009-07-30 | Takeda Pharmaceutical Company Limited | Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
| TW201004941A (en) | 2008-07-16 | 2010-02-01 | Wyeth Corp | Alpha7 nicotinic acetylcholine receptor inhibitors |
| CN102414180A (zh) | 2009-03-02 | 2012-04-11 | 西特里斯药业公司 | 作为沉默调节蛋白调节剂的8-取代的喹啉及相关的类似物 |
| CA2852964A1 (en) | 2011-11-03 | 2013-05-10 | F. Hoffmann-La Roche Ag | Bicyclic piperazine compounds |
| GB201321728D0 (en) * | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
-
2015
- 2015-05-22 KR KR1020167035803A patent/KR20170005868A/ko unknown
- 2015-05-22 AU AU2015261775A patent/AU2015261775B2/en active Active
- 2015-05-22 BR BR112016024749A patent/BR112016024749A2/pt not_active IP Right Cessation
- 2015-05-22 EA EA201692405A patent/EA030604B1/ru not_active IP Right Cessation
- 2015-05-22 MX MX2016014483A patent/MX2016014483A/es unknown
- 2015-05-22 CA CA2948436A patent/CA2948436A1/en not_active Abandoned
- 2015-05-22 JP JP2016568812A patent/JP6580074B2/ja active Active
- 2015-05-22 CN CN201580026356.5A patent/CN106414448B/zh active Active
- 2015-05-22 ES ES15724640.6T patent/ES2620751T3/es active Active
- 2015-05-22 EP EP15724640.6A patent/EP2991990B1/en active Active
- 2015-05-22 WO PCT/EP2015/061468 patent/WO2015177367A1/en active Application Filing
- 2015-05-22 US US15/312,762 patent/US9771372B2/en active Active
-
2016
- 2016-08-11 HK HK16109566.7A patent/HK1221463A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US9771372B2 (en) | 2017-09-26 |
| JP6580074B2 (ja) | 2019-09-25 |
| BR112016024749A2 (pt) | 2017-08-15 |
| US20170204098A1 (en) | 2017-07-20 |
| EA030604B1 (ru) | 2018-08-31 |
| ES2620751T3 (es) | 2017-06-29 |
| WO2015177367A1 (en) | 2015-11-26 |
| CN106414448A (zh) | 2017-02-15 |
| AU2015261775A1 (en) | 2016-12-08 |
| MX2016014483A (es) | 2017-01-23 |
| CN106414448B (zh) | 2019-04-19 |
| EA201692405A1 (ru) | 2017-06-30 |
| EP2991990A1 (en) | 2016-03-09 |
| JP2017516772A (ja) | 2017-06-22 |
| EP2991990B1 (en) | 2017-02-01 |
| KR20170005868A (ko) | 2017-01-16 |
| CA2948436A1 (en) | 2015-11-26 |
| AU2015261775B2 (en) | 2019-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL250345A0 (en) | new compounds | |
| IL250592A0 (en) | new compounds | |
| IL248991B (en) | Converted dihydroisoquinolinone compounds | |
| GB201417011D0 (en) | Novel compounds | |
| GB201417094D0 (en) | Novel compounds | |
| GB201417018D0 (en) | Novel compounds | |
| SG11201606693SA (en) | Novel compounds | |
| GB201405991D0 (en) | Novel compounds | |
| GB201411236D0 (en) | Novel compounds | |
| GB201411239D0 (en) | Novel compounds | |
| GB201404002D0 (en) | Novel compounds | |
| IL248983A0 (en) | new compounds | |
| HK1221463A1 (zh) | 可用作 抑制劑的新型化合物 | |
| GB201419102D0 (en) | Novel compounds | |
| GB201407506D0 (en) | Novel compound | |
| ZA201605726B (en) | Novel compounds | |
| GB201421834D0 (en) | Novel compounds | |
| GB201421784D0 (en) | Novel compounds | |
| GB201417021D0 (en) | Novel compounds | |
| GB201417041D0 (en) | Novel compounds | |
| GB201417043D0 (en) | Novel compounds | |
| GB201414614D0 (en) | Novel compounds | |
| GB201413451D0 (en) | Novel compounds | |
| GB201413260D0 (en) | Novel compounds | |
| GB201412689D0 (en) | Novel compounds |